Table III.

Thirty-day event rates for symptomatic patients undergoing CEA and CAS stratified by risk group

	CEA patients
	HR (n = 936)	Non-HR (n = 1470)	P value
MACE	7.3%	4.6%	<.01
Stroke, death	6.4%	3.9%	<.01
Mortality	1.8%	0.6%	<.01
Stroke	4.9%	3.5%	.09
MI	1.4%	1.1%	.57
	CAS patients
	HR (n = 1538)	Non-HR (n = 162)	P value
MACE	9.1%	6.2%	.25
Stroke, death	7.9%	4.9%	.21
Mortality	2.4%	1.9%	1.00
Stroke	6.7%	3.7%	.18
MI	1.4%	1.2%	1.00

CAS, Carotid artery stenting; CEA, carotid endarterectomy; HR, high risk; MACE, major adverse cardiovascular events; MI, myocardial infarction.